Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lydia, Kernitsky"'
Autor:
Juliann M. Paolicchi, Yu-Tze Ng, Joan A. Conry, Rima Veidemanis, Jouko Isojarvi, Lydia Kernitsky, Wendy G. Mitchell, Rebecca Drummond, Deborah Lee
Publikováno v:
Epilepsia
To determine long-term safety and efficacy of adjunctive clobazam for patients with Lennox-Gastaut syndrome (LGS).Eligible patients from two randomized controlled trials (Phase II OV-1002 and Phase III OV-1012) were able to enroll in open-label exten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::344be064cbecc176aae6a6c0c0e52de3
http://europepmc.org/articles/PMC4303987
http://europepmc.org/articles/PMC4303987
Autor:
Yu-Tze, Ng, Joan, Conry, Juliann, Paolicchi, Lydia, Kernitsky, Wendy, Mitchell, Rebecca, Drummond, Jouko, Isojarvi, Deborah, Lee, Randall, Owen, Brenda Y, Wu
Publikováno v:
Epilepsy & Behavior. 25:687-694
In an ongoing open-label extension (OV-1004), patients with Lennox-Gastaut syndrome who had completed 1 of 2 randomized controlled trials (OV-1002 [Phase II] or OV-1012 [Phase III]) are receiving clobazam at dosages ≤2.0 mg/kg/day (≤80 mg/day). O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3bc291342f51172c74e311a992bbe5d
https://doi.org/10.1016/j.yebeh.2012.09.039
https://doi.org/10.1016/j.yebeh.2012.09.039
Autor:
Juliann M. Paolicchi, Radhi Abdulnabi, Lydia Kernitsky, Stephen D. Collins, Julie Stolle, Frank J. Ritter, Joan A. Conry, Wendy G. Mitchell, Bill Riley, Yu-Tze Ng, Katherine Tracy, William N. Kormany
Publikováno v:
Epilepsia. 50:1158-1166
SUMMARY Purpose: This randomized, double-blind, doseranging study evaluated safety and efficacy of clobazam (CLB) as adjunctive therapy for drop seizures in patients with Lennox-Gastaut syndrome (LGS). Methods: Sixty-eight patients with LGS aged 2–
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::782690f194fbe4d6cb57fb8c906eaba7
https://doi.org/10.1111/j.1528-1167.2008.01935.x
https://doi.org/10.1111/j.1528-1167.2008.01935.x
Publikováno v:
Epilepsia. 46(3)
Summary: Purpose: To determine whether valproic acid [divalproex (DVP)] extended-release, administered at a higher proportionate once-daily dosage, can be safely substituted for delayed-release or sprinkle in pediatric patients with epilepsy. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::882d70a7c6c8a7f4f9edf35b752e37d2
https://pubmed.ncbi.nlm.nih.gov/15730542
https://pubmed.ncbi.nlm.nih.gov/15730542